Expression of human papillomavirus type 16 E7 oncoprotein alters keratinocytes expression profile in response to tumor necrosis factor-alpha. 2010

Enrique Boccardo, and Carina Victoria Manzini Baldi, and Alex Fiorini Carvalho, and Tatiana Rabachini, and César Torres, and Luiz André Barreta, and Helena Brentani, and Luisa Lina Villa
Virology Group, Ludwig Institute for Cancer Research, São Paulo 01323-903, Brazil. eboccardo@ludwig.org.br

Acute expression of E7 oncogene from human papillomavirus (HPV) 16 or HPV18 is sufficient to overcome tumor necrosis factor (TNF)-alpha cytostatic effect on primary human keratinocytes. In the present study, we investigated the molecular basis of E7-induced TNF resistance through a comparative analysis of the effect of this cytokine on the proliferation and global gene expression of normal and E7-expressing keratinocytes. Using E7 functional mutants, we show that E7-induced TNF resistance correlates with its ability to mediate pRb degradation and cell transformation. On the other hand, this effect does not depend on E7 sequences required to override DNA damage-induced cell cycle arrest or extend keratinocyte life span. Furthermore, we identified a group of 66 genes whose expression pattern differs between normal and E7-expressing cells upon cytokine treatment. These genes are mainly involved in cell cycle regulation suggesting that their altered expression may contribute to sustained cell proliferation even in the presence of a cytostatic stimulus. Differential expression of TCN1 (transcobalamin I), IFI44 (Interferon-induced protein 44), HMGB2 (high-mobility group box 2) and FUS [Fusion (involved in t(12;16) in malignant liposarcoma)] among other genes were further confirmed by western-blot and/or real-time polymerase chain reaction. Moreover, FUS upregulation was detected in HPV-positive cervical high-grade squamous intraepithelial lesions when compared with normal cervical tissue. Further evaluation of the role of such genes in TNF resistance and HPV-associated disease development is warranted.

UI MeSH Term Description Entries
D008297 Male Males
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D002472 Cell Transformation, Viral An inheritable change in cells manifested by changes in cell division and growth and alterations in cell surface properties. It is induced by infection with a transforming virus. Transformation, Viral Cell,Viral Cell Transformation,Cell Transformations, Viral,Transformations, Viral Cell,Viral Cell Transformations
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D004249 DNA Damage Injuries to DNA that introduce deviations from its normal, intact structure and which may, if left unrepaired, result in a MUTATION or a block of DNA REPLICATION. These deviations may be caused by physical or chemical agents and occur by natural or unnatural, introduced circumstances. They include the introduction of illegitimate bases during replication or by deamination or other modification of bases; the loss of a base from the DNA backbone leaving an abasic site; single-strand breaks; double strand breaks; and intrastrand (PYRIMIDINE DIMERS) or interstrand crosslinking. Damage can often be repaired (DNA REPAIR). If the damage is extensive, it can induce APOPTOSIS. DNA Injury,DNA Lesion,DNA Lesions,Genotoxic Stress,Stress, Genotoxic,Injury, DNA,DNA Injuries
D004261 DNA Replication The process by which a DNA molecule is duplicated. Autonomous Replication,Replication, Autonomous,Autonomous Replications,DNA Replications,Replication, DNA,Replications, Autonomous,Replications, DNA
D004351 Drug Resistance Diminished or failed response of an organism, disease or tissue to the intended effectiveness of a chemical or drug. It should be differentiated from DRUG TOLERANCE which is the progressive diminution of the susceptibility of a human or animal to the effects of a drug, as a result of continued administration. Resistance, Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated

Related Publications

Enrique Boccardo, and Carina Victoria Manzini Baldi, and Alex Fiorini Carvalho, and Tatiana Rabachini, and César Torres, and Luiz André Barreta, and Helena Brentani, and Luisa Lina Villa
March 1992, Journal of virology,
Enrique Boccardo, and Carina Victoria Manzini Baldi, and Alex Fiorini Carvalho, and Tatiana Rabachini, and César Torres, and Luiz André Barreta, and Helena Brentani, and Luisa Lina Villa
August 2017, Virology,
Enrique Boccardo, and Carina Victoria Manzini Baldi, and Alex Fiorini Carvalho, and Tatiana Rabachini, and César Torres, and Luiz André Barreta, and Helena Brentani, and Luisa Lina Villa
September 2008, Journal of virology,
Enrique Boccardo, and Carina Victoria Manzini Baldi, and Alex Fiorini Carvalho, and Tatiana Rabachini, and César Torres, and Luiz André Barreta, and Helena Brentani, and Luisa Lina Villa
October 1990, Biochemical and biophysical research communications,
Enrique Boccardo, and Carina Victoria Manzini Baldi, and Alex Fiorini Carvalho, and Tatiana Rabachini, and César Torres, and Luiz André Barreta, and Helena Brentani, and Luisa Lina Villa
March 2009, Virology,
Enrique Boccardo, and Carina Victoria Manzini Baldi, and Alex Fiorini Carvalho, and Tatiana Rabachini, and César Torres, and Luiz André Barreta, and Helena Brentani, and Luisa Lina Villa
January 2018, Journal of Cancer,
Enrique Boccardo, and Carina Victoria Manzini Baldi, and Alex Fiorini Carvalho, and Tatiana Rabachini, and César Torres, and Luiz André Barreta, and Helena Brentani, and Luisa Lina Villa
June 2001, The Journal of biological chemistry,
Enrique Boccardo, and Carina Victoria Manzini Baldi, and Alex Fiorini Carvalho, and Tatiana Rabachini, and César Torres, and Luiz André Barreta, and Helena Brentani, and Luisa Lina Villa
October 1992, Journal of immunology (Baltimore, Md. : 1950),
Enrique Boccardo, and Carina Victoria Manzini Baldi, and Alex Fiorini Carvalho, and Tatiana Rabachini, and César Torres, and Luiz André Barreta, and Helena Brentani, and Luisa Lina Villa
May 2000, Journal of virology,
Enrique Boccardo, and Carina Victoria Manzini Baldi, and Alex Fiorini Carvalho, and Tatiana Rabachini, and César Torres, and Luiz André Barreta, and Helena Brentani, and Luisa Lina Villa
October 2015, Cancer science,
Copied contents to your clipboard!